Abstract
The aim of this study was to describe the prevalence and characteristics of knee prosthetic joint infections due to extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae. From 2000 to 2007, 132 infections out of 5,076 arthroplasties (2.6%) were registered. Seven out of 132 infections (5.3%) were due to ESBL-producing Enterobacteriaceae, Escherichia coli in six cases and Klebsiella pneumoniae in one. Open debridement and retention of the implant was the first surgical approach and all patients received intravenous carbapenems. Relapse was documented in four cases and remission in three. Therefore, debridement without prosthesis removal was associated with a high failure rate.
This is a preview of subscription content, log in via an institution to check access.
References
Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I, Atkins BL (2007) Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect 55:1–7
Nijssen S, Florijn A, Bonten MJ, Schmitz FJ, Verhoef J, Fluit AC (2004) Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents 24:585–591
Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I et al (2006) Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42:925–934
Mirelis B, Navarro F, Miró E, Mesa RJ, Coll P, Prats G (2003) Community transmission of extended-spectrum beta-lactamase. Emerg Infect Dis 9:1024–1025
Barberán J, Aguilar L, Carroquino G, Giménez MJ, Sánchez B, Martínez D et al (2006) Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med 119:993.e7–993.e10
Soriano A, García S, Bori G, Almela M, Gallart X, Macule F et al (2006) Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect 12:930–933
Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE (1998) Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. JAMA 279:1537–1541
Brouqui P, Rousseau MC, Stein A, Drancourt M, Raoult D (1995) Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime–ciprofloxacin antibiotic combination. Antimicrob Agents Chemother 39:2423–2425
Legout L, Senneville E, Stern R, Yazdanpanah Y, Savage C, Roussel-Delvalez M et al (2006) Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime–fluoroquinolone combination. Clin Microbiol Infect 12:1030–1033
Tanaka G, Shigeta M, Komatsuzawa H, Sugai M, Suginaka H, Usui T (1999) Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents: beta-lactams and fluoroquinolones. Chemotherapy 45:28–36
Bagge N, Schuster M, Hentzer M, Ciofu O, Givskov M, Greenberg EP et al (2004) Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. Antimicrob Agents Chemother 48:1175–1187
Jones RN, Pfaller MA (2003) Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum beta-lactamase in Europe. Clin Microbiol Infect 9:708–712
Conflicts of interest
None to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martínez-Pastor, J.C., Vilchez, F., Pitart, C. et al. Antibiotic resistance in orthopaedic surgery: acute knee prosthetic joint infections due to extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae . Eur J Clin Microbiol Infect Dis 29, 1039–1041 (2010). https://doi.org/10.1007/s10096-010-0950-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-010-0950-y